학술논문
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
Document Type
Article
Author
Source
In Annals of Oncology February 2014 25(2):366-371
Subject
Language
ISSN
0923-7534